Biochimica et Biophysica Acta: Reviews on Cancer
Издатель: Elsevier · ISSN 0304-419X · 90 статей
- Neuronal regulation of cancer: Mechanisms, functional consequences and therapeutic opportunities
- Post-translational modifications in prostate cancer: coordinated oncogenic networks and clinical implications
- Sex hormone-binding globulin as a context-dependent regulator of sex steroid bioavailability in cancers
- iPSC models of hereditary cancer predisposition: Mechanistic insights into premalignant evolution and lineage-specific vulnerability
- Systemic therapy-induced resistance and toxicity in breast cancer: Sensitization and mitigation strategies
- SNARE proteins: Core engines of membrane fusion in cancer
- CARM1 in human cancer: a multifunctional epigenetic node driving tumor plasticity and therapeutic vulnerability
- B-MYB (MYBL2): from cell cycle regulator to an oncogenic player
- Immunopeptidomics in gliomas: Decoding antigen presentation for precision immunotherapy
- Long non-coding RNAs as master regulators of cancer metastasis and therapeutic resistance
- From smoke to stemness: Mechanisms of cancer stem cell induction by cigarette smoke
- Corrigendum to ‘PTEN: Redefining tumor suppressor functions in cancer by regulating transcription’ [Biochimica et Biophysica Acta (BBA) – Reviews on Cancer, Volume 1881 (2026) 189659]
- Endothelial dysfunction in cancer: A neglected frontier in anticancer therapy
- Metabolic and epigenetic plasticity of tumor-associated macrophages shapes immunosuppressive outputs and immune checkpoint response
- Tertiary lymphoid structures in pancreatic cancer: molecular mechanisms, heterogeneity, and clinical significance
- Metabolic regulation of tumor angiogenesis in colorectal cancer: mechanisms and therapeutic opportunities
- Antibody–drug conjugates in treatment-resistant hepatocellular carcinoma: mechanistic insights, translational barriers, and a blueprint for salvage-line precision oncology
- SOX4: A pivotal transcriptional hub and potential therapeutic target in hepatocellular carcinoma progression
- Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment
- Engineered nano-delivery platforms targeting ferroptosis-evasion pathways to reverse tumor drug resistance
- Metabolic matching shapes organ-specific metastasis
- Nanomedicine-based strategies to counter chemoresistance in diffuse large B-cell lymphoma
- Single-cell and spatial transcriptomic technologies for lung cancer tumor microenvironment analysis
- Metabolic reprogramming of myeloid antigen-presenting cells in the tumor microenvironment: mechanisms of antigen presentation failure and therapeutic opportunities
- Advances in single-cell and spatial multi-omics for deciphering the mechanisms of pan-organ metastasis in breast cancer
- Targeting ferroptosis as a new paradigm for overcoming sorafenib resistance in hepatocellular carcinoma
- Advances in the regulation of vascular function by stromal cells in the tumour microenvironment of tongue squamous cell carcinoma and prospects for treatment
- Metabolic reprogramming in T-cell acute lymphoblastic leukemia: Mechanisms of therapy resistance and clinical applications
- From molecular characteristics to clinical practice: current status and future prospects of immunotherapy for SMARCA4-deficient tumors
- WNT/β-catenin signaling: implications for homeostasis and tumorigenesis in the esophagus